DanDi Bioscience

HLB Science, xxxselected for excellence in healthcare R&D in 2022 

The Ministry of Health and Welfare task we are carrying out was xxxselected as ‘2022 Health Care R&D Outstanding Achievement’ by the Korea Health Industry Development Institute.

The Korea Health Industry Development Institute's '2022 Healthcare R&D Excellence' xxxselects studies that have performed excellently in 2021 through committee evaluation.

Our company was xxxselected as a 3-year task in 2020 for "DD-S052 non-clinical test completion and preparation for clinical phase 1 approval" as an infectious disease prevention and treatment technology development project, and is currently carrying out the 3-year task.

As for the contents of excellence, the 2022 Healthcare R&D Excellence and Casebook will be published in December this year.